JP2011510936A5 - - Google Patents

Download PDF

Info

Publication number
JP2011510936A5
JP2011510936A5 JP2010544590A JP2010544590A JP2011510936A5 JP 2011510936 A5 JP2011510936 A5 JP 2011510936A5 JP 2010544590 A JP2010544590 A JP 2010544590A JP 2010544590 A JP2010544590 A JP 2010544590A JP 2011510936 A5 JP2011510936 A5 JP 2011510936A5
Authority
JP
Japan
Prior art keywords
urea
layer
present
therapeutic system
transdermal therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010544590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011510936A (ja
JP5389824B2 (ja
Filing date
Publication date
Priority claimed from DE102008006791A external-priority patent/DE102008006791B4/de
Application filed filed Critical
Publication of JP2011510936A publication Critical patent/JP2011510936A/ja
Publication of JP2011510936A5 publication Critical patent/JP2011510936A5/ja
Application granted granted Critical
Publication of JP5389824B2 publication Critical patent/JP5389824B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010544590A 2008-01-30 2008-12-09 尿素成分を有する経皮治療システム Expired - Fee Related JP5389824B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008006791A DE102008006791B4 (de) 2008-01-30 2008-01-30 Transdermales Therapeutisches System mit Harnstoff-Komponente und Verfahren zu dessen Herstellung
DE102008006791.1 2008-01-30
PCT/EP2008/010426 WO2009095057A2 (de) 2008-01-30 2008-12-09 Transdermales therapeutisches system mit harnstoff-komponente

Publications (3)

Publication Number Publication Date
JP2011510936A JP2011510936A (ja) 2011-04-07
JP2011510936A5 true JP2011510936A5 (https=) 2011-07-21
JP5389824B2 JP5389824B2 (ja) 2014-01-15

Family

ID=40386379

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010544590A Expired - Fee Related JP5389824B2 (ja) 2008-01-30 2008-12-09 尿素成分を有する経皮治療システム

Country Status (14)

Country Link
US (1) US9066887B2 (https=)
EP (1) EP2234605B1 (https=)
JP (1) JP5389824B2 (https=)
KR (1) KR20100105866A (https=)
CN (1) CN101909607B (https=)
AU (1) AU2008349007B2 (https=)
BR (1) BRPI0821975B8 (https=)
CA (1) CA2710640C (https=)
DE (1) DE102008006791B4 (https=)
ES (1) ES2548295T3 (https=)
MX (1) MX2010008334A (https=)
PL (1) PL2234605T3 (https=)
WO (1) WO2009095057A2 (https=)
ZA (1) ZA201004012B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106333939A (zh) * 2016-10-09 2017-01-18 常州亚环环保科技有限公司 一种药用透皮材料的制备方法
CN109549929A (zh) * 2017-09-27 2019-04-02 天津金耀集团有限公司 一种有机固体溶液降低皮质激素药物粒径的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
CS164542B1 (https=) * 1973-02-15 1975-11-07
DE2964135D1 (en) * 1978-06-16 1983-01-05 Phares Pharm Res Nv Pharmaceutical compositions containing urea
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
US4699777A (en) * 1985-08-21 1987-10-13 Schering Corporation Compositions and method for enhancement of the transdermal flux of albuterol with a combination of 1-dodecyl-azacyclopheptan-2-one and urea
US5230896A (en) * 1989-10-12 1993-07-27 Warner-Lambert Company Transdermal nicotine delivery system
DE4210165A1 (de) 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
DE4310012A1 (de) 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
AU2576797A (en) * 1996-04-22 1997-11-12 Toyama Chemical Co. Ltd. Patch containing 1,2-ethanediol derivatives or salts thereof
DE19701949A1 (de) 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
FR2761889B1 (fr) * 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
EP1331929A1 (en) * 2000-11-06 2003-08-06 Samyang Corporation Transdermal drug delivery system with improved water absorbability and adhesion properties
ATE341314T1 (de) * 2000-12-15 2006-10-15 Schering Ag Mikronisierten harnstoff enthaltende wasserfreie hautpflegezusammensezung und verfahren zu ihrer herstellung
US20050020658A1 (en) * 2002-11-21 2005-01-27 Katsuyuki Inoo Selective cyclooxygenase-2 inhibitor patch
FR2867978B1 (fr) * 2004-03-29 2009-02-20 Galderma Res & Dev Patch d'amorolfine pour le traitement de l'onychomicose
DE102004028284A1 (de) 2004-06-11 2006-01-05 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin

Similar Documents

Publication Publication Date Title
JP2010510260A5 (https=)
JP5881935B2 (ja) 活性物質の利用率及び用量精度の高い経皮治療システム
JP2016504368A5 (https=)
JP5542665B2 (ja) マトリックス型経皮投与剤およびその製造方法
Cilurzo et al. Application of methyl methacrylate copolymers to the development of transdermal or loco-regional drug delivery systems
JP2016502989A5 (https=)
JP2013079281A5 (https=)
BR112012019374A2 (pt) composição farmacêutica, pellet de liberação prolongada, composição farmacêutica oral, método para tratamento de uma doença neurodegenerativa ou um dano ao sistema nervoso em um indivíduo necessitado do mesmo e método para preparação de uma formulação de liberação prolongada de um agente ativo
JP2017039781A5 (https=)
NZ589542A (en) Transdermal drug delivery system comprising an active agent in amorphous form and polyvinylpyrrolidone
EP3160461A1 (en) Transdermal delivery system
JP2017515872A5 (https=)
JP2008517934A5 (https=)
DE50311477D1 (de) Hormonhaltiges transdermales therapeutisches system mit einem wirkstoffreservoir auf der basis von vinylacetat-vinylpyrrolidon-copolymer mit verbesserter kohäsion.
JP2011510936A5 (https=)
JP6516917B2 (ja) 貼付剤
US20170071880A1 (en) Selegiline transdermal system
HK1220125A1 (zh) 拉喹莫德的透皮配方
JPH10330247A5 (https=)
JP5389824B2 (ja) 尿素成分を有する経皮治療システム
JP7063537B2 (ja) ラベンダー油を含有する経皮治療システム
JP7685984B2 (ja) アクリルポリマーおよび接着剤組成物
HRP20170292T1 (hr) Transdermalni flasteri niske doze s visokim otpuštanjem lijeka
HK1151716B (en) Transdermal therapeutic system having urea components
JP2018507850A5 (https=)